Skip to search formSkip to main contentSkip to account menu

YM-08310

Known as: YM 08310, YM08310 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AmifostineAmifostine Trihydrate
WR-2721

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Clinical usefulness of amifostine (YM-08310, WR-2721) as a radioprotective agent
Radioprotective effects of amifostine were established for acute radiation injury using mucositis in the oral cavity and diarrhea… 
1987
1987
[Responses to radiation of Ehrlich ascites tumor cells in the presence of YM-08310 (=WR-2721) and/or Ro-07-0582 (in vivo, in vitro assay)].
Highly Cited
1986
Highly Cited
1986
Clinical study of the radioprotective effects of Amifostine (YM-08310, WR-2721) on chronic radiation injury.
1985
1985
[An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 2. Abdominal and pelvic tumors].
1985
1985
[An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumors].
1984
1984
[Clinical use of radioprotector amifostine (YM-08310)].
1983
1983
[Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].
1982
1982
Clinical Study of Radioprotective Effects of YM-08310 in Patients with Carcinoma of the Cervix Uteri
1982
1982
[Radioprotective effect of YM-08310 in radiotherapy of cervical cancer].
1978
1978
[Radioprotective effects of YM-08310 on normal and malignant tissues (author's transl)].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)